114 related articles for article (PubMed ID: 18510489)
1. Metabolic syndrome and target organ damage: role of blood pressure.
Cuspidi C; Sala C; Zanchetti A
Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):731-43. PubMed ID: 18510489
[TBL] [Abstract][Full Text] [Related]
2. Increasing number of components of the metabolic syndrome and cardiac structural and functional abnormalities--cross-sectional study of the general population.
Azevedo A; Bettencourt P; Almeida PB; Santos AC; Abreu-Lima C; Hense HW; Barros H
BMC Cardiovasc Disord; 2007 Jun; 7():17. PubMed ID: 17555566
[TBL] [Abstract][Full Text] [Related]
3. Mediators of target organ damage in hypertension: focus on obesity associated factors and inflammation.
Dawood T; Schlaich MP
Minerva Cardioangiol; 2009 Dec; 57(6):687-704. PubMed ID: 19942842
[TBL] [Abstract][Full Text] [Related]
4. Prehypertension is associated with insulin resistance state and not with an initial renal function impairment. A Metabolic Syndrome in Active Subjects in Spain (MESYAS) Registry substudy.
Cordero A; Laclaustra M; León M; Grima A; Casasnovas JA; Luengo E; del Rio A; Ferreira I; Alegria E
Am J Hypertens; 2006 Feb; 19(2):189-96; discussion 197-8. PubMed ID: 16448891
[TBL] [Abstract][Full Text] [Related]
5. Age and target organ damage in essential hypertension: role of the metabolic syndrome.
Cuspidi C; Meani S; Valerio C; Sala C; Fusi V; Zanchetti A; Mancia G
Am J Hypertens; 2007 Mar; 20(3):296-303. PubMed ID: 17324743
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome in subjects with essential hypertension: relationships with subclinical cardiovascular and renal damage.
Mulé G; Cottone S; Nardi E; Andronico G; Cerasola G
Minerva Cardioangiol; 2006 Apr; 54(2):173-94. PubMed ID: 16778751
[TBL] [Abstract][Full Text] [Related]
7. [Glomerular filtration rate and cardiovascular risk: prognostic and therapeutic implications].
Ratto E; Leoncini G; Viazzi F; Pontremoli R
G Ital Nefrol; 2008; 25(1):21-31. PubMed ID: 18264915
[TBL] [Abstract][Full Text] [Related]
8. The metabolic syndrome and chronic kidney disease.
Peralta CA; Kurella M; Lo JC; Chertow GM
Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):361-5. PubMed ID: 16775449
[TBL] [Abstract][Full Text] [Related]
9. Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population.
Mancia G; Bombelli M; Facchetti R; Madotto F; Corrao G; Trevano FQ; Giannattasio C; Grassi G; Sega R
J Hypertens; 2008 Aug; 26(8):1602-11. PubMed ID: 18622239
[TBL] [Abstract][Full Text] [Related]
10. Ambulatory heart rate and target organ damage in never-treated essential hypertensives.
Cuspidi C; Valerio C; Meani S; Sala C; Esposito A; Masaidi M; Negri F; Giudici V; Zanchetti A; Mancia G
J Hum Hypertens; 2008 Feb; 22(2):89-95. PubMed ID: 17823595
[TBL] [Abstract][Full Text] [Related]
11. Vascular permeability, blood pressure, and organ damage in primary hypertension.
Viazzi F; Leoncini G; Ratto E; Parodi A; Falqui V; Conti N; Tomolillo C; Ravera G; Deferrari G; Pontremoli R
Hypertens Res; 2008 May; 31(5):873-9. PubMed ID: 18712042
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic interventions for hypertension in metabolic syndrome: a comprehensive approach.
Ganne S; Arora S; Karam J; McFarlane SI
Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):201-11. PubMed ID: 17338665
[TBL] [Abstract][Full Text] [Related]
13. Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes.
Ryu S; Chang Y; Woo HY; Lee KB; Kim SG; Kim DI; Kim WS; Suh BS; Jeong C; Yoon K
Am J Kidney Dis; 2009 Jan; 53(1):59-69. PubMed ID: 18838200
[TBL] [Abstract][Full Text] [Related]
14. Changes in insulin sensitivity, renal function, and markers of endothelial dysfunction in hypertension--the impact of microalbuminuria: a 13-year follow-up study.
Solbu MD; Jenssen TG; Eriksen BO; Toft I
Metabolism; 2009 Mar; 58(3):408-15. PubMed ID: 19217459
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome and cardiometabolic risk: an update.
Grassi G; Seravalle G; Quarti-Trevano F; Dell'Oro R; Bombelli M; Mancia G
Blood Press; 2009; 18(1-2):7-16. PubMed ID: 19148840
[TBL] [Abstract][Full Text] [Related]
16. [Left ventricular hypertrophy among hypertensive patients with diminished glomerular filtration rate].
Grabysa R; Cholewa M
Pol Merkur Lekarski; 2008 Oct; 25(148):309-14. PubMed ID: 19145927
[TBL] [Abstract][Full Text] [Related]
17. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
[TBL] [Abstract][Full Text] [Related]
18. Metabolic syndrome and heart failure.
Thethi T; Bratcher C; Fonseca V
Heart Fail Clin; 2006 Jan; 2(1):1-11. PubMed ID: 17386872
[No Abstract] [Full Text] [Related]
19. Target organ damage and associated clinical conditions in newly diagnosed hypertensives attending a tertiary health facility.
Ayodele OE; Alebiosu CO; Akinwusi PO; Akinsola A; Mejiuni A
Niger J Clin Pract; 2007 Dec; 10(4):319-25. PubMed ID: 18293643
[TBL] [Abstract][Full Text] [Related]
20. [Cardiorenal syndrome in ischemic renal disease (atherosclerotic renovascular hypertension)].
Mukhin NA; Fomin VV; Moiseev SV; Shvetsov MIu; Kutyrina IM; Zaĭtsev AIu; Taronishvili OI
Ter Arkh; 2008; 80(8):30-8. PubMed ID: 18807537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
